BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3282012)

  • 1. Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity.
    Smeenk RJ; Van Rooijen A; Swaak TJ
    J Immunol Methods; 1988 Apr; 109(1):27-35. PubMed ID: 3282012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance.
    Nossent JC; Huysen V; Smeenk RJ; Swaak AJ
    Ann Rheum Dis; 1989 Aug; 48(8):677-82. PubMed ID: 2789501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).
    Swaak T; Smeenk R
    Ann Rheum Dis; 1985 Apr; 44(4):245-51. PubMed ID: 3872637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of DNA/anti-DNA complexes. II. Salt lability and avidity.
    Riley RL; Addis DJ; Taylor RP
    J Immunol; 1980 Jan; 124(1):1-7. PubMed ID: 6985634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
    Smeenk R; van der Lelij G; Aarden L
    J Immunol; 1982 Jan; 128(1):73-8. PubMed ID: 7033379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibodies to DNA: a technical assessment.
    Smeenk R; Hylkema M
    Mol Biol Rep; 1992 Nov; 17(1):71-9. PubMed ID: 1287479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay.
    Smeenk R; van der Lelij G; Aarden L
    Clin Exp Immunol; 1982 Sep; 49(3):603-10. PubMed ID: 6756723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low avidity antibodies to dsDNA as a diagnostic tool.
    Nossent JC; Huysen V; Smeenk RJ; Swaak AJ
    Ann Rheum Dis; 1989 Sep; 48(9):748-52. PubMed ID: 2802796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-dsDNA: choice of assay in relation to clinical value.
    Smeenk RJ; van den Brink HG; Brinkman K; Termaat RM; Berden JH; Swaak AJ
    Rheumatol Int; 1991; 11(3):101-7. PubMed ID: 1754810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of low avidity anti-DNA antibodies in systemic lupus erythematosus.
    Riley RL; McGrath H; Taylor RP
    Arthritis Rheum; 1979 Mar; 22(3):219-25. PubMed ID: 311203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test.
    Werle E; Blazek M; Fiehn W
    Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus.
    Smeenk R; Aarden L
    J Immunol Methods; 1980; 39(1-2):165-80. PubMed ID: 7007509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients.
    Hylkema MN; van Bruggen MC; ten Hove T; de Jong J; Swaak AJ; Berden JH; Smeenk RJ
    J Autoimmun; 2000 Mar; 14(2):159-68. PubMed ID: 10677247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus.
    McGrath H; Biundo JJ
    Arthritis Rheum; 1985 Apr; 28(4):425-30. PubMed ID: 3885960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of anti-native DNA antibodies by immunofluorescence on Crithidia luciliae. Correlation between renal involvement and the presence of high-avidity anti-native DNA antibodies in lupic disease].
    Meyer O; Borda-Iriarte O; Haïm T; Ryckewaert A
    Presse Med; 1984 Dec; 13(46):2801-5. PubMed ID: 6240645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring.
    Villalta D; Romelli PB; Savina C; Bizzaro N; Tozzoli R; Tonutti E; Ghirardello A; Doria A
    Lupus; 2003; 12(1):31-6. PubMed ID: 12587824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity in systemic lupus erythematosus of antibodies to double-stranded DNA measured with the polyethylene glycol precipitation assay.
    Smeenk R; van der Lelij G; Swaak T; Groenwold J; Aarden L
    Arthritis Rheum; 1982 Jun; 25(6):631-8. PubMed ID: 7092963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP; Trabandt A; Grobe N; Werle E
    Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
    Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.
    Adu D; Dobson J; Williams DG
    Clin Exp Immunol; 1981 Mar; 43(3):605-14. PubMed ID: 6974627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.